R&D channel feed

4DMT's gene ther­a­py re­duced need for stan­dard-of-care in­jec­tions to treat age-as­so­ci­at­ed vi­sion loss

8 months ago
Cell/Gene Tx

Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

8 months ago
Pharma

With few ef­fi­ca­cy de­tails, In­sil­i­co claims a Phase 2a win in lat­est AI read­out

8 months ago
AI

You bet your life: Af­ter I was di­ag­nosed with a rare can­cer, I dis­cov­ered how a small band of physi­cian-sci­en­tists trig­gered a rev­o­lu­tion

8 months ago
Bioregnum

Con­duct­ing tri­als via rou­tine clin­i­cal prac­tice: FDA ex­plains how in new draft guid­ance

8 months ago
FDA+

Sun, sur­pris­es and new sum­mits at Eu­rope’s biggest can­cer con­fer­ence

8 months ago
Pharma

Af­ter land­ing a key win in a com­mon can­cer con­di­tion, Pfiz­er faces a big test in Phase 3

8 months ago
Pharma

Mer­ck and Dai­ichi’s re­ject­ed HER3 ADC clears a Phase 3 in cer­tain lung can­cers

8 months ago

Nu­ra Bio rais­es $68M for clin­i­cal tests of SARM1 in­hibitor to po­ten­tial­ly slow or pre­vent nerve de­gen­er­a­tion

8 months ago
Financing

Em­met Stephen­son gives $150M to City of Hope for pan­cre­at­ic can­cer, cre­at­ing mil­lion-dol­lar re­search prize

8 months ago
Financing

23andMe heads to ES­MO to tout its two clin­i­cal-stage drugs af­ter scrap­ping dis­cov­ery team

8 months ago
Startups

FDA tells on­col­o­gy com­pa­nies how to run mul­ti-re­gion­al can­cer tri­als with a US ap­proval in mind

8 months ago
FDA+

Boehringer plans NDA fil­ing for pul­monary fi­bro­sis drug fol­low­ing Phase 3 da­ta

8 months ago

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

8 months ago

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

8 months ago
Deals

Mer­ck­'s Eli­av Barr on sub­cu­ta­neous Keytru­da, Sum­mit and deal shop­ping

8 months ago
People

Ex­elix­is’ drug staves off neu­roen­docrine tu­mor pro­gres­sion in broad swath of pa­tients

8 months ago

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

8 months ago
Pharma
Coronavirus

Keytru­da and Lenvi­ma still have an­oth­er hill to climb fol­low­ing lat­est da­ta drop

8 months ago
Pharma

As­traZeneca un­veils what it calls ‘prac­tice-chang­ing’ Imfinzi da­ta in blad­der can­cer

8 months ago
Pharma

Scor­pi­on de­tails ear­ly da­ta on tar­get­ed breast can­cer drug as it seeks to chal­lenge No­var­tis, Roche

8 months ago

In­cyte gears up to face FDA once again with more Zynyz da­ta in rare anal can­cer

8 months ago
Pharma

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

8 months ago

Up­dat­ed: Bris­tol My­ers touts LAG-3 strat­e­gy in lung can­cer, but da­ta caveats damp­en ex­cite­ment

8 months ago
First page Previous page 26272829303132 Next page Last page
A service from the Financial Times